Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1160 | 2814 | 32.4 | 61% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
411 | 3 | CONTRACEPTION//AMFITEATRU ECONOMIC//ECTOPIC PREGNANCY | 29326 |
1131 | 2 | CONTRACEPTION//EMERGENCY CONTRACEPTION//INTRAUTERINE DEVICE | 9621 |
1160 | 1 | ORAL CONTRACEPTIVES//CONTRACEPTION//DESOGESTREL | 2814 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ORAL CONTRACEPTIVES | authKW | 1412715 | 18% | 26% | 497 |
2 | CONTRACEPTION | journal | 847939 | 22% | 13% | 616 |
3 | DESOGESTREL | authKW | 701693 | 4% | 60% | 107 |
4 | ETHINYLESTRADIOL | authKW | 683541 | 7% | 31% | 201 |
5 | CYCLE CONTROL | authKW | 630117 | 2% | 88% | 66 |
6 | GESTODENE | authKW | 457203 | 3% | 59% | 72 |
7 | COMBINED ORAL CONTRACEPTIVES | authKW | 378879 | 3% | 42% | 84 |
8 | DROSPIRENONE | authKW | 373847 | 3% | 38% | 90 |
9 | NORGESTIMATE | authKW | 300031 | 2% | 63% | 44 |
10 | ORAL CONTRACEPTION | authKW | 287069 | 3% | 34% | 77 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Obstetrics & Gynecology | 115933 | 61% | 1% | 1714 |
2 | Reproductive Biology | 3623 | 7% | 0% | 206 |
3 | Medicine, General & Internal | 1552 | 12% | 0% | 345 |
4 | Family Studies | 1295 | 3% | 0% | 77 |
5 | Peripheral Vascular Diseases | 640 | 5% | 0% | 145 |
6 | Endocrinology & Metabolism | 614 | 7% | 0% | 194 |
7 | Public, Environmental & Occupational Health | 561 | 7% | 0% | 200 |
8 | Demography | 557 | 1% | 0% | 34 |
9 | Hematology | 424 | 5% | 0% | 128 |
10 | Social Sciences, Biomedical | 363 | 2% | 0% | 47 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ABT HAMOSTASIOL | 32548 | 0% | 100% | 3 |
2 | TEVA BRANDED PHARMACEUT PROD | 32548 | 0% | 100% | 3 |
3 | ZEG | 32548 | 0% | 100% | 3 |
4 | CLIN STAT EUROPE | 24410 | 0% | 75% | 3 |
5 | ER 9 | 24410 | 0% | 75% | 3 |
6 | GYNAECOL PERINATOL CHILDCARE | 21699 | 0% | 100% | 2 |
7 | HOSP NEUKOELLN | 21699 | 0% | 100% | 2 |
8 | JIANGSU PLANNED PARENTHOOD | 21699 | 0% | 100% | 2 |
9 | MED DEV FEMALE CONTRACEPT | 21699 | 0% | 100% | 2 |
10 | O 101 | 21699 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CONTRACEPTION | 847939 | 22% | 13% | 616 |
2 | EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE | 120760 | 3% | 12% | 93 |
3 | AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 19781 | 7% | 1% | 192 |
4 | JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE | 16749 | 1% | 5% | 30 |
5 | BRITISH JOURNAL OF FAMILY PLANNING | 11400 | 1% | 7% | 16 |
6 | CONTRACEPTION FERTILITE SEXUALITE | 11311 | 1% | 3% | 35 |
7 | ADVANCES IN CONTRACEPTION | 9834 | 0% | 7% | 13 |
8 | GYNECOLOGICAL ENDOCRINOLOGY | 8645 | 2% | 2% | 49 |
9 | INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE | 7642 | 1% | 4% | 16 |
10 | FAMILY PLANNING PERSPECTIVES | 7145 | 1% | 2% | 29 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ORAL CONTRACEPTIVES | 1412715 | 18% | 26% | 497 | Search ORAL+CONTRACEPTIVES | Search ORAL+CONTRACEPTIVES |
2 | DESOGESTREL | 701693 | 4% | 60% | 107 | Search DESOGESTREL | Search DESOGESTREL |
3 | ETHINYLESTRADIOL | 683541 | 7% | 31% | 201 | Search ETHINYLESTRADIOL | Search ETHINYLESTRADIOL |
4 | CYCLE CONTROL | 630117 | 2% | 88% | 66 | Search CYCLE+CONTROL | Search CYCLE+CONTROL |
5 | GESTODENE | 457203 | 3% | 59% | 72 | Search GESTODENE | Search GESTODENE |
6 | COMBINED ORAL CONTRACEPTIVES | 378879 | 3% | 42% | 84 | Search COMBINED+ORAL+CONTRACEPTIVES | Search COMBINED+ORAL+CONTRACEPTIVES |
7 | DROSPIRENONE | 373847 | 3% | 38% | 90 | Search DROSPIRENONE | Search DROSPIRENONE |
8 | NORGESTIMATE | 300031 | 2% | 63% | 44 | Search NORGESTIMATE | Search NORGESTIMATE |
9 | ORAL CONTRACEPTION | 287069 | 3% | 34% | 77 | Search ORAL+CONTRACEPTION | Search ORAL+CONTRACEPTION |
10 | NUVARING | 218792 | 1% | 92% | 22 | Search NUVARING | Search NUVARING |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | (2017) COMBINED HORMONAL CONTRACEPTION AND THE RISK OF VENOUS THROMBOEMBOLISM: A GUIDELINE.FERTILITY AND STERILITY. VOL. 107. ISSUE 1. P. 43 -51 | 77 | 91% | 0 |
2 | NAPPI, RE , KAUNITZ, AM , BITZER, J , (2016) EXTENDED REGIMEN COMBINED ORAL CONTRACEPTION: A REVIEW OF EVOLVING CONCEPTS AND ACCEPTANCE BY WOMEN AND CLINICIANS.EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE. VOL. 21. ISSUE 2. P. 106 -115 | 70 | 85% | 0 |
3 | PANICKER, S , MANN, S , SHAWE, J , STEPHENSON, J , (2014) EVOLUTION OF EXTENDED USE OF THE COMBINED ORAL CONTRACEPTIVE PILL.JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE. VOL. 40. ISSUE 2. P. 133-141 | 67 | 89% | 3 |
4 | GOURDY, P , BACHELOTH, A , CATTEAU-JONARD, S , CHABBERT-BUFFET, N , CHRISTIN-MAITRE, S , CONARD, J , FREDENRICH, A , GOMPEL, A , LAMICHE-LORENZINI, F , MOREAU, C , ET AL (2012) HORMONAL CONTRACEPTION IN WOMEN AT RISK OF VASCULAR AND METABOLIC DISORDERS: GUIDELINES OF THE FRENCH SOCIETY OF ENDOCRINOLOGY.ANNALES D ENDOCRINOLOGIE. VOL. 73. ISSUE 5. P. 469 -487 | 75 | 78% | 11 |
5 | NEWTON, JR , (1995) CLASSIFICATION AND COMPARISON OF ORAL CONTRACEPTIVES CONTAINING NEW GENERATION PROGESTOGENS.HUMAN REPRODUCTION UPDATE. VOL. 1. ISSUE 3. P. 231-263 | 132 | 69% | 47 |
6 | JACOBSON, JC , LIKIS, FE , MURPHY, PA , (2012) EXTENDED AND CONTINUOUS COMBINED CONTRACEPTIVE REGIMENS FOR MENSTRUAL SUPPRESSION.JOURNAL OF MIDWIFERY & WOMENS HEALTH. VOL. 57. ISSUE 6. P. 585-592 | 59 | 92% | 6 |
7 | BRACHE, V , PAYAN, LJ , FAUNDES, A , (2013) CURRENT STATUS OF CONTRACEPTIVE VAGINAL RINGS.CONTRACEPTION. VOL. 87. ISSUE 3. P. 264-272 | 63 | 77% | 15 |
8 | SITRUK-WARE, R , NATH, A , (2011) METABOLIC EFFECTS OF CONTRACEPTIVE STEROIDS.REVIEWS IN ENDOCRINE & METABOLIC DISORDERS. VOL. 12. ISSUE 2. P. 63 -75 | 62 | 78% | 36 |
9 | GALLO, MF , LOPEZ, LM , GRIMES, DA , CARAYON, F , SCHULZ, KF , HELMERHORST, FM , (2014) COMBINATION CONTRACEPTIVES: EFFECTS ON WEIGHT.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 1. P. - | 62 | 78% | 3 |
10 | MACGREGOR, EA , (2013) CONTRACEPTION AND HEADACHE.HEADACHE. VOL. 53. ISSUE 2. P. 247-276 | 80 | 60% | 8 |
Classes with closest relation at Level 1 |